ARDELYX INC. - COMMON STOCK

Ardelyx Responds to District Court Decision Granting Motion to Dismiss

08 نوفمبر 2024 12:31:21 بحسب Nasdaq GlobeNewswire

Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference

05 نوفمبر 2024 08:00:32 بحسب Nasdaq GlobeNewswire

Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update

31 أكتوبر 2024 16:02:40 بحسب Nasdaq GlobeNewswire

Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting

28 أكتوبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week

24 أكتوبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community

22 أكتوبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community

21 أكتوبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024

17 أكتوبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week

15 أكتوبر 2024 08:00:20 بحسب Nasdaq GlobeNewswire

Ardelyx Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology

09 أكتوبر 2024 08:05:00 بحسب Nasdaq GlobeNewswire

Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference

05 سبتمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer

08 أغسطس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update

01 أغسطس 2024 16:01:02 بحسب Nasdaq GlobeNewswire

Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion

31 يوليو 2024 08:02:00 بحسب Nasdaq GlobeNewswire

Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024

18 يوليو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines

17 يوليو 2024 17:10:43 بحسب Nasdaq GlobeNewswire

To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA

02 يوليو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines

28 يونيو 2024 08:17:59 بحسب Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

30 مايو 2024 16:02:00 بحسب Nasdaq GlobeNewswire

Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference

22 مايو 2024 08:02:00 بحسب Nasdaq GlobeNewswire